Curanex Pharmaceuticals Inc Common Stock (CURX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Curanex Pharmaceuticals Inc Common Stock (CURX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.7M, listed on NASDAQ, carrying a beta of -3.22 to the broader market. Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. Led by Jun Liu, public since 2025-08-26.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for CURX as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →